Abstract:Acinetobacter baumannii causes pneumonias, bacteremias, and skin and soft tissue infections, primarily in the hospitalized setting. The incidence of infections caused by A. baumannii has increased dramatically over the last 30 years, while at the same time the treatment of these infections has been complicated by the emergence of antibiotic-resistant strains. Despite these trends, no vaccines or antibody-based therapies have been developed for the prevention of A. baumannii infection. In this study, an outer m… Show more
“…In vivo pathogenesis comparison between A. baumannii strains. Traditionally, bacterial sepsis models used for study of A. baumannii utilize porcine mucin to enhance virulence of the bacterium through inhibition of phagocytosis (13,43,44). Consequently, LD 50 values as low as 10 3 to 10 4 CFU have been reported, with time to death (TTD) near 1 week postchallenge (13,14).…”
“…In vivo pathogenesis comparison between A. baumannii strains. Traditionally, bacterial sepsis models used for study of A. baumannii utilize porcine mucin to enhance virulence of the bacterium through inhibition of phagocytosis (13,43,44). Consequently, LD 50 values as low as 10 3 to 10 4 CFU have been reported, with time to death (TTD) near 1 week postchallenge (13,14).…”
“…Vaccine made of outer membrane complexes (OMCs) from A. baumannii induced protective humoral and cellular immune responses against murine sepsis model [158]. Similarly, passive transfer of antiserum from immunized murine to naive mice rescued these mice from…”
Multidrug-resistant bacteria (MDR) are increasing rapidly and posing a global threat to mankind. Alternative strategies other than antibiotics have to be explored urgently. In this chapter, we review the current status of nonantibiotics strategies including antibodybased therapy and vaccine development for targeting Gram-positive strains (methicillinresistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium) and MDR Gram-negative strains (Acinetobacter baumannii and Pseudomonas aeruginosa). Biologicsbased clinical progress against these bacterial infections is updated.
“…[26][27][28][29] Of tremendous import, an Omp vaccine with multiple surface antigens from the bacterial membrane of A. baumannii elicited protective and therapeutic humoral and cellular responses in a murine sepsis model. 30 How well will this serve as a start to a vaccine remains to be seen.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.